Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 20:09 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Phase not reported / not applicableCompletedOBSERVATIONAL
Start: 2003-10-01. Completion: 2005-02-28 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Org 36286 (drug) — also listed as: Corifollitropin alfa
recFSH (drug) — also listed as: Follitropin Beta, Puregon®, Follistim®
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Start: 2021-08-16. Completion: 2021-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Low dose hCG (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Reproductive Medicine Associates of New Jersey Basking Ridge, New Jersey, United States Site recruitment: Not reported
Women's Hospital School Of Medicine Zhejiang University
Countries with listed sites
China
Registry dates and results
Start: 2022-01-12. Completion: 2024-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
abnormal pre-pregnancy test results that need clinical intervention (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Women's Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China Site recruitment: Recruiting
Start: 2017-07-28. Completion: 2018-01-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
intrauterine injection of HCG (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Reproductive & Genetic Hospital of CITIC-XIANGYA Changsha, Hunan, China Site recruitment: Not reported
Start: 2018-12-10. Completion: 2019-10-16 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
HCG (drug)
culture medium (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Reproductive & Genetic Hospital of CITIC-XIANGYA Changsha, Hunan, China Site recruitment: Not reported
Start: 2017-11-15. Completion: 2021-08-18 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Follitropin Beta;MSD (drug) — also listed as: Puregon
Ganirelix (drug) — also listed as: Orgalutran
hCG (drug) — also listed as: Ovidrel
estradiol valerate (drug) — also listed as: progynova
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Reproductive & Genetic Hospital of Citic-Xiangya Changsha, Hunan, China Site recruitment: Not reported
Start: 2018-07-18. Completion: 2019-11-20 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
human menopausal gonadotrophin (drug)
hormone replacement therapy (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Reproductive & Genetic Hospital of CITIC-XIANGYA Changsha, Hunan, China Site recruitment: Not reported
Start: 2021-08-17. Completion: 2023-08-17 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Medical treatment (drug) — also listed as: Surgical treatment
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Maria Dolores Reguera Saborido Benguela, Angola Site recruitment: Recruiting
Start: 2016-12. Completion: 2020-06 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
hCG (drug)
Progesterone (drug) — also listed as: Prontogest
Triptorelin (drug) — also listed as: Decapeptyl
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
AinShams Maternity Hospital Cairo, Egypt Site recruitment: Not reported
Female Infertility Due to Diminished Ovarian Reserve
Sponsor
Cairo University
Countries with listed sites
Egypt
Registry dates and results
Start: 2014-07. Completion: 2015-07 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Growth Hormone (drug) — also listed as: Norditropin, Novo nordisk
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Kasr Al Aini Cairo, Egypt Site recruitment: Not reported
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Sponsor
Mansoura University
Countries with listed sites
No country reported
Registry dates and results
Start: 2021-11. Completion: 2023-12 (may be estimated). No results posted in this registry response.
Products and interventions (7)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Dydrogesterone Tablets (drug)
cetrorelix 0.25mg (drug)
human menopausal gonadotropin (drug)
triptorelin 0.1 mg (drug)
human chorionic gonadotropin (drug)
cryopreservation (procedure)
Estradiol Valerate and progesterone (drug)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Start: 2021-03-29. Completion: 2021-08-09 (may be estimated). No results posted in this registry response.
Products and interventions (9)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Covidir injections (drug) — also listed as: Experimental drug administration
One Step Test (diagnostic_test) — also listed as: Covid-19 test
IgM and IgG dosage (diagnostic_test) — also listed as: Blood test
RT-PCR SARS-CoV-2 (diagnostic_test) — also listed as: Covid-19 test
Screening blood test (diagnostic_test) — also listed as: Blood test
ECG (diagnostic_test) — also listed as: Electrocardiogram
Medical evaluation (diagnostic_test) — also listed as: Physical examination
NEWS-2 score (diagnostic_test)
WHO score (diagnostic_test)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Hospital Vera Cruz S A (Campinas-SP) Campinas, State of São Paulo, Brazil Site recruitment: Not reported
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Center for reproductive medicine, Barnaul Barnaul, Russia Site recruitment: Not reported
Center for reproductive medicine, Irkutsk Irkutsk, Russia Site recruitment: Not reported
Clinic "Mother and Child" Kazan Kazan', Russia Site recruitment: Not reported
Clinic "Mother and Child" Kostroma Kostroma, Russia Site recruitment: Not reported
Clinic "Mother and Child" Krasnodar Krasnodar, Russia Site recruitment: Not reported
Center for reproductive medicine, Krasnoyarsk Krasnoyarsk, Russia Site recruitment: Not reported
AltraVita IVF clinic Moscow, Russia Site recruitment: Not reported
Center of Reproductive Medicine and Genetics "Nova Clinic" Moscow, Russia Site recruitment: Not reported
Clinic "Mather and Child" Lefortovo Moscow, Russia Site recruitment: Not reported
Clinic "Mather and Child" Savelovskaya Moscow, Russia Site recruitment: Not reported
Clinic "Mother and Child" Khodynskoe Pole Moscow, Russia Site recruitment: Not reported
Clinic "Mother and Child" Kuntsevo Moscow, Russia Site recruitment: Not reported
Clinic "Mother and Child" South-West Moscow, Russia Site recruitment: Not reported
Clinical Hospital MD GROUP (Perinatal Center on Sevastopolskiy) Moscow, Russia Site recruitment: Not reported
Clinical Hospital Lapino Moscow Oblast, Russia Site recruitment: Not reported
Clinic "Mother and Child" Nizhny Novgorod, Russia Site recruitment: Not reported
Poor Response to Ovulation Induction Poseidon Type IV
Sponsor
Ain Shams Maternity Hospital
Countries with listed sites
Egypt
Registry dates and results
Start: 2021-10-09. Completion: 2022-12-30 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Growth Hormone (drug)
Clomiphene citrate daily and recombinant FSH (Gonal-F®) (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
AinShams University Cairo, Egypt Site recruitment: Recruiting
Start: 2018-10-01. Completion: 2021-03-31 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Longer administration of estradiol (Progynova®) (other) — also listed as: comparing 7 vs 14 days of administration of estradiol (Progynova®) for artificially prepared endometrium in frozen embryo transfer
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Universitair Ziekenhuis Brussel Brussels, Belgium Site recruitment: Not reported
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Countries with listed sites
Turkey (Türkiye)
Registry dates and results
Start: 2021-04-01. Completion: 2021-09-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Serum thyroid function tests (diagnostic_test) — also listed as: Beta HCG and thyroid peroxidase antibody, Thyroid ultrasonography
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Sehit Prof Dr Ilhan Varank Sancaktepe Training and Research Hospital Istanbul, Turkey (Türkiye) Site recruitment: Not reported
Start: 2020-02-09. Completion: 2021-12-01 (may be estimated). No results posted in this registry response.
Products and interventions (0)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Al-BARAKA FERTILITY HOSPITAL Manama, Adliya, Bahrain Site recruitment: Recruiting
Start: 2021-11-01. Completion: 2022-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Acupuncture and Chinese Herbal Medicine (other)
Where the study takes place — 12 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China Site recruitment: Not reported
The First Hospital of Lanzhou University Lanzhou, Gansu, China Site recruitment: Not reported
The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China Site recruitment: Not reported
Tongji Hospital, Tongji Medical College Huazhong University of Science & Technology Wuhan, Hubei, China Site recruitment: Not reported
Huaian Maternal and Child Health Hospital Huai'an, Jiangsu, China Site recruitment: Not reported
The First Affiliated Hospital of Nanjing University Medical School (Nanjing Drum Tower Hospital) Nanjing, Jiangsu, China Site recruitment: Not reported
Xuzhou Central Hospital Xuzhou, Jiangsu, China Site recruitment: Not reported
Jiangxi Maternal and Child Health Hospital Nanchang, Jiangxi, China Site recruitment: Not reported
Dalian Municipal Women and Children's Medical Center Dalian, Liaoning, China Site recruitment: Not reported
Shengjing Hospital of China Medical University Shenyang, Liaoning, China Site recruitment: Not reported
Xibei Women and Children's Hospital Xi’an, Shanxi, China Site recruitment: Not reported
The Chinese University of Hong Kong Hong Kong, China Site recruitment: Not reported
Reproductive Health Training Center of the Republic of Moldova
Countries with listed sites
Moldova
Registry dates and results
Start: 2020-03-20. Completion: 2021-03-31 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Medical abortion (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Reproductive Health Training Center Chisinau, Moldova Site recruitment: Not reported
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.
Medika-2
Site recruitment: Not reported
Center for reproductive medicine, Novosibirsk Novosibirsk, Russia Site recruitment: Not reported
Clinical Hospital "Avicenna" Novosibirsk, Russia Site recruitment: Not reported
Ceter for reproductive medicine, Omsk Omsk, Russia Site recruitment: Not reported
Clinic "Mother and Child" Perm Perm, Russia Site recruitment: Not reported
Clinic "Mother and Child" Rostov-on-Don Rostov-on-Don, Russia Site recruitment: Not reported
Clinic "Mather and Child" Ryazan, Russia Site recruitment: Not reported
"Genesis" Reproduction Centre Saint Petersburg, Russia Site recruitment: Not reported
Clinic "Mother and Child" Saint-Petersburg Saint Petersburg, Russia Site recruitment: Not reported
Clinical Hospital "Mother and Child" Samara, Russia Site recruitment: Not reported
Clinic "Mather and Child" Tula Tula, Russia Site recruitment: Not reported
Clinical Hospital "Mother and Child" Tyumen, Russia Site recruitment: Not reported
Clinical Hospital "Mother and Child" Ufa, Russia Site recruitment: Not reported
Clinic "Mother and Child" Vladimir Vladimir, Russia Site recruitment: Not reported
Clinic "Mather and Child" Vladivostok Vladivostok, Russia Site recruitment: Not reported
Clinic "Mother and Child" Volgograd Volgograd, Russia Site recruitment: Not reported
Clinic "Mother and Child" Voronezh Voronezh, Russia Site recruitment: Not reported
Clinic "Mother and Child" Yaroslavl Yaroslavl, Russia Site recruitment: Not reported
Clinical Institute of Reproductive Medicine Yekaterinburg, Russia Site recruitment: Not reported